4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001628280-26-021543
Chief Medical Officer sold 5,500 shares at $18.95 ($104,229)
- Chief Medical Officer acquired 5,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raben David Chief Medical Officer | 2026-03-25 | Option exercise 10b5-1 | +5,500 | $3.79 | $20,844 | 60,786 | D |
| Raben David Chief Medical Officer | 2026-03-25 | Sale 10b5-1 | −5,500 | $18.95 | $104,229 | 55,286 | D |
| Derivatives | |||||||
| Raben David Chief Medical Officer | 2026-03-25 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,500 | 47,413 | D | ||
| Open-market sales · 5,500 sh · avg $18.95 · $104,229 | |||||||
Loading xslF345X06/wk-form4_1774567271.xml…